{
  "abstract": "Efforts to improve transparency around the payments that drug companies make to doctors, which could influence their practice, have been hit by an “appalling” lack of progress, experts warn.",
  "authors": [
    {
      "affiliations": [
        "Belfast"
      ],
      "name": "Chris Baraniuk"
    }
  ],
  "title": "Drug industry payments: “Appalling” lack of progress on transparency",
  "uid": "739ec45b-fa61-5fcb-940c-75bad4efd074"
}
